Clinical trials in acute myocardial infarction: should we adjust for baseline characteristics? (Q53913222)

22 May 2018

title

Clinical trials in acute myocardial infarction: should we adjust for baseline characteristics? (English)

1 reference

22 May 2018

acute myocardial infarction

main subject

myocardial infarction

1 reference

based on heuristic

inferred from title

1 reference

Steyerberg EW

1

1 reference

22 May 2018

Bossuyt PM

series ordinal

2

1 reference

22 May 2018

Lee KL

series ordinal

3

1 reference

22 May 2018

language of work or name

English

0 references

publication date

1 May 2000

1 reference

22 May 2018

published in

American Heart Journal

1 reference

22 May 2018

volume

139

1 reference

22 May 2018

page(s)

745-751

1 reference

22 May 2018

issue

5

1 reference

22 May 2018

Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990001-2

An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990001-2

Adjunctive drug therapy of acute myocardial infarction--evidence from clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990001-2

A comparison of reteplase with alteplase for acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990001-2

A comparison of continuous infusion of alteplase with double-bolus administration for acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990001-2

A Comparison of Recombinant Hirudin with Heparin for the Treatment of Acute Coronary Syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990001-2

Randomisation and baseline comparisons in clinical trials.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990001-2

Suspended judgment. Significance tests of covariate imbalance in clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990001-2

Testing for baseline balance in clinical trials.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990001-2

Short-term risk stratification at admission based on simple clinical data in acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990001-2

Predictors of early morbidity and mortality after thrombolytic therapy of acute myocardial infarction. Analyses of patient subgroups in the Thrombolysis in Myocardial Infarction (TIMI) trial, phase II

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990001-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990001-2

Hospital mortality in acute myocardial infarction in the era of reperfusion therapy (the myocardial infarction triage and intervention project)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990001-2

Age and outcome with contemporary thrombolytic therapy. Results from the GUSTO-I trial. Global Utilization of Streptokinase and TPA for Occluded coronary arteries trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990001-2

Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41,021 patients. GUSTO-I Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990001-2

A note on a general definition of the coefficient of determination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990001-2

A quantitative study of the bias in estimating the treatment effect caused by omitting a balanced covariate in survival models.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990001-2

Model inconsistency, illustrated by the Cox proportional hazards model.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990001-2

Effects of covariate omission and categorization when analysing randomized trials with the Cox model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990001-2

Should we adjust for covariates in nonlinear regression analyses of randomized trials?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990001-2

An evidence based approach to individualising treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990001-2

Selection of thrombolytic therapy for individual patients: development of a clinical model. GUSTO-I Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990001-2

Reperfusion therapy for acute myocardial infarction. Which strategy for which patient?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990001-2

Coronary risk estimation and treatment of hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990001-2

Predictive value of statistical models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990001-2

The risk of determining risk with multivariable models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990001-2

Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990001-2

Recent methodological contributions to clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990001-2

Biostatistical methodology in clinical trials in applications for marketing authorizations for medicinal products. CPMP Working Party on Efficacy of Medicinal Products Note for Guidance III/3630/92-EN

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990001-2

On model prespecification in confirmatory randomized studies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990001-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990001-2

10.1016/S0002-8703(00)90001-2

7 January 2021

Identifiers

DOI

1 reference

22 May 2018

PubMed ID

10783203

1 reference

22 May 2018